Amphotericin B Liposome Drug Interactions: 7 Major
Amphotericin B Liposome Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Amphotericin B Liposome. Always confirm against the full prescribing information.
100 interactions
Aceclofenac
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Aceclofenac.
Level 2 evidence
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amphotericin B.
Level 1 evidence
Acetazolamide
The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Amphotericin B.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Acetylsalicylic acid.
Level 2 evidence
Acyclovir
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Acyclovir.
Level 2 evidence
Adefovir dipivoxil
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Adefovir dipivoxil.
Level 2 evidence
Alendronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Alendronic acid.
Level 2 evidence
Amifampridine
The risk or severity of seizure can be increased when Amphotericin B is combined with Amifampridine.
Level 2 evidence
Amikacin
Amphotericin B may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amobarbital
Amobarbital may increase the hypotensive activities of Amphotericin B.
Level 2 evidence
Antipyrine
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Antipyrine.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Amphotericin B is combined with Articaine.
Amphotericin B Liposome has 943 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Amphotericin B Liposome has 7 major, 291 moderate, and 645 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Amphotericin B Liposome. Always confirm against the full prescribing information.